Connection

Daynna Wolff to In Situ Hybridization, Fluorescence

This is a "connection" page, showing publications Daynna Wolff has written about In Situ Hybridization, Fluorescence.
  1. Guidance for fluorescence in situ hybridization testing in hematologic disorders. J Mol Diagn. 2007 Apr; 9(2):134-43.
    View in: PubMed
    Score: 0.296
  2. Fluorescence in situ hybridization for detecting transitional cell carcinoma: implications for clinical practice. BJU Int. 2005 Dec; 96(9):1280-5.
    View in: PubMed
    Score: 0.270
  3. Novel high-risk acute myeloid leukemia subgroup with ERG amplification and Biallelic loss of TP53. Cancer Genet. 2023 04; 272-273:23-28.
    View in: PubMed
    Score: 0.221
  4. Integrated genomic analysis using chromosomal microarray, fluorescence in situ hybridization and mate pair analyses: Characterization of a cryptic t(9;22)(p24.1;q11.2)/BCR-JAK2 in myeloid/lymphoid neoplasm with eosinophilia. Cancer Genet. 2020 08; 246-247:44-47.
    View in: PubMed
    Score: 0.187
  5. A multicenter, cross-platform clinical validation study of cancer cytogenomic arrays. Cancer Genet. 2015 Nov; 208(11):525-36.
    View in: PubMed
    Score: 0.133
  6. Evaluation of urovysion and cytology for bladder cancer detection: a study of 1835 paired urine samples with clinical and histologic correlation. Cancer Cytopathol. 2013 Oct; 121(10):591-7.
    View in: PubMed
    Score: 0.114
  7. Association of age with fluorescence in situ hybridization abnormalities in multiple myeloma reveals higher rate of IGH translocations among older patients. Leuk Lymphoma. 2012 Dec; 53(12):2444-8.
    View in: PubMed
    Score: 0.106
  8. Validation of fluorescence in situ hybridization using an analyte-specific reagent for detection of abnormalities involving the mixed lineage leukemia gene. Arch Pathol Lab Med. 2012 Jan; 136(1):47-52.
    View in: PubMed
    Score: 0.103
  9. Clonal diversity analysis using SNP microarray: a new prognostic tool for chronic lymphocytic leukemia. Cancer Genet. 2011 Dec; 204(12):654-65.
    View in: PubMed
    Score: 0.102
  10. The utility of fluorescence in situ hybridization (FISH) analysis in diagnosing graft versus host disease following orthotopic liver transplant. Ann Clin Lab Sci. 2011; 41(2):188-92.
    View in: PubMed
    Score: 0.096
  11. HER2 testing: a review of detection methodologies and their clinical performance. Expert Rev Mol Diagn. 2007 Jan; 7(1):53-64.
    View in: PubMed
    Score: 0.073
  12. The genetics of bladder cancer: a cytogeneticist's perspective. Cytogenet Genome Res. 2007; 118(2-4):177-81.
    View in: PubMed
    Score: 0.073
  13. Pediatric T-cell acute lymphoblastic leukemia with aberrations of both MLL loci. Cancer Genet Cytogenet. 2006 Jul 01; 168(1):77-9.
    View in: PubMed
    Score: 0.070
  14. Abnormal fluorescence in situ hybridization analysis in collecting duct carcinoma. Urology. 2005 Nov; 66(5):1110.
    View in: PubMed
    Score: 0.067
  15. A case of infantile acute myelogenous leukemia with MLL-MLL10 fusion caused by insertion of 11q into 10p. Cancer Genet Cytogenet. 2005 Jun; 159(2):181-3.
    View in: PubMed
    Score: 0.065
  16. Urothelial carcinoma of donor origin in a kidney transplant patient. J Immunother Cancer. 2016; 4:63.
    View in: PubMed
    Score: 0.036
  17. Comparison Between HER2, Estrogen Receptors and Progesterone Receptors in Primary Breast Carcinomas and Matched Lymph Node Metastases. Turk Patoloji Derg. 2016; 32(3):178-85.
    View in: PubMed
    Score: 0.034
  18. "Low-Fat" Pseudoangiomatous Spindle Cell Lipoma: A Rare Variant With Loss of 13q14 Region. Am J Dermatopathol. 2015 Dec; 37(12):920-3.
    View in: PubMed
    Score: 0.034
  19. Tetraploidy and 5q deletion in myelodysplastic syndrome: a case report. Cancer Genet Cytogenet. 2008 May; 183(1):64-8.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.